Biote Corp Class A (BTMD)
$1.11 -5.13% Close Oct 30, 2026 Live
Biote stock today
Biote closed at $1.11 on October 30, 2026, down 5.13% on the day. Over the past year it returned -60.1% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $42.0 million.
$1.00$2.00$3.00
NovJan 2026MarMayJulSep
| Period | BTMD | S&P 500 (SPY) |
|---|---|---|
| 1 month | -8.3% | -0.9% |
| 3 months | -50.0% | +2.1% |
| Year to date | -57.3% | +11.7% |
| 1 year | -60.1% | +12.4% |
| 3 years | -78.8% | +88.5% |
| 5 years | -88.6% | +76.0% |
Key statistics
- Market value
- $42.0M
- P/E (trailing)
- 11.1
- Forward P/E
- 2.8
- Price / sales
- 0.2
- 52-week range
- $1.03 to $2.93
- Next report
- Nov 4, 2026
About Biote
Bioidentical hormone replacement therapy pellet provider for hormone optimization and wellness treatment.
Sector: Health Care
More on Biote
- Financials: revenue, earnings and segmentsRevenue -3% in the year to Dec 2025
- Valuation: P/E history and peersP/E 11.1, median 38.0 at its last 3 year ends
- Returns: what $1,000 became$1,000 five years ago is $113.85 today
No forecast, no recommendation. This page describes Biote Corp Class A from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.